South Africa Non-opioid Pain Treatment Market Size & Outlook

Revenue, 2024 (US$M)
$0.0
Forecast, 2030 (US$M)
$0.0
CAGR, 2025 - 2030
0%
Report Coverage
South Africa

South Africa non-opioid pain treatment market, 2018-2030 (US$M)

South

South Africa non-opioid pain treatment market highlights

  • The South Africa non-opioid pain treatment market generated a revenue of USD 417.4 million in 2021 and is expected to reach USD 881.5 million by 2030.
  • The South Africa market is expected to grow at a CAGR of 8.7% from 2022 to 2030.
  • In terms of segment, local anesthetics was the largest revenue generating drug class in 2021.
  • Acetaminophen is the most lucrative drug class segment registering the fastest growth during the forecast period.


Non-opioid pain treatment market data book summary

Market revenue in 2021USD 417.4 million
Market revenue in 2030USD 881.5 million
Growth rate8.7% (CAGR from 2021 to 2030)
Largest segmentLocal anesthetics
Fastest growing segmentAcetaminophen
Historical data2018 - 2020
Base year2021
Forecast period2022 - 2030
Quantitative unitsRevenue in USD million
Market segmentationNSAIDs, Acetaminophen, Local Anesthetics
Key market players worldwideNovartis AG ADR, Teva Pharmaceutical Industries Ltd, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, GSK PLC ADR, Pfizer Inc, Perrigo Co PLC, LNK International Inc., Cipla Ltd DR, Johnson & Johnson, Pacira BioSciences Inc, Pierrel S.p.A


Other key industry trends

  • In terms of revenue, South Africa accounted for 1.1% of the global non-opioid pain treatment market in 2021.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, Saudi Arabia non-opioid pain treatment market is projected to lead the regional market in terms of revenue in 2030.
  • UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 649.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Non-opioid Pain Treatment Market Scope

Non-opioid pain treatment market segmentation & scope
Selective COX-2 Inhibitors
Non-Selective NSAIDs
Acetaminophen
Local Anesthetics
Others
Pain Type
Chronic Pain
Neuropathic Pain
Inflammatory Conditions
Post-operative Pain
Cancer Pain
Others
Route of Administration
Oral
Topical
Injectable
Others
Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others

Non-opioid Pain Treatment Market Companies

Name Profile # Employees HQ Website

South Africa non-opioid pain treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-opioid pain treatment market will help companies and investors design strategic landscapes.


Local anesthetics was the largest segment with a revenue share of 42.24% in 2024. Horizon Databook has segmented the South Africa non-opioid pain treatment market based on nsaids, acetaminophen, local anesthetics covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to South Africa non-opioid pain treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Africa non-opioid pain treatment market databook

  • Our clientele includes a mix of non-opioid pain treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Africa non-opioid pain treatment market , including forecasts for subscribers. This country databook contains high-level insights into South Africa non-opioid pain treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Africa non-opioid pain treatment market

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more